1. Peripheral Mechanism of Cancer-Induced Bone Pain
   Yachen Yang et al, 2023, Neuroscience Bulletin CrossRef
2. Combining anticancer drugs with osteoprotective agents in prostate cancer—A contemporary update
   Igor Tsaur et al, 2018, Urologic Oncology: Seminars and Original Investigations CrossRef
3. The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
   Yan Zhang et al, 2022, Frontiers in Endocrinology CrossRef
4. Therapeutic approaches for protecting bone health in patients with breast cancer
   Diana Lüftner et al, 2018, The Breast CrossRef
5. Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis
   Tianhao Zhu et al, 2020, Frontiers in Oncology CrossRef
6. Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer
   Salik Abdullah et al, 2024, Journal of Environmental Pathology, Toxicology and Oncology CrossRef
7. Pharmacological and mechanistic aspects of quercetin in osteoporosis
   Ting-Ting Deng et al, 2024, Frontiers in Pharmacology CrossRef
8. Bone Microenvironment and Role of Rank-Rankl-Opg in Breast Cancer Metastasis in Bone
   Hongwei Zhang, 2017, Journal of Cancer Prevention & Current Research CrossRef
9. 24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo
   Anjali Verma et al, 2019, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
10. Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
    Anne Gomez-Brouchet et al, 2021, Cancers CrossRef
11. mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model
    Chiara Spadazzi et al, 2019, Journal of Bone Oncology CrossRef
12. The Signaling Pathways Associated With Breast Cancer Bone Metastasis
    Xuelian Song et al, 2022, Frontiers in Oncology CrossRef
13. Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis
    Sivakumar Vijayaraghavalu et al, 2020, Biomaterials CrossRef
14. Expression of Receptor Activator of Nuclear – Kappa β Ligand in Patients with Metastatic Bone Disease
    Rahadyan Magetsari et al, 2022, Open Access Macedonian Journal of Medical Sciences CrossRef
15. Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy
    Eleni Timotheadou et al, 2017, Translational Oncology CrossRef
16. Bone turnover markers and novel biomarkers in lung cancer bone metastases
    Jiangli Lang et al, 2018, Biomarkers CrossRef
17. CaSR Induces Osteoclast Differentiation and Promotes Bone Metastasis in Lung Adenocarcinoma
    Lian Liu et al, 2020, Frontiers in Oncology CrossRef
18. Carbon/Inorganic Hybrid Nanoarchitectures as Carriers for Signaling Elements in Electrochemical Immunosensors: First Biosensor for the Determination of the Inflammatory and Metastatic Processes Biomarker RANK‐ligand
    Alejandro Valverde et al, 2020, ChemElectroChem CrossRef
19. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions
    Hyo Shik Shin et al, 2021, Thyroid CrossRef
20. Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
    Emanuela Palmerini et al, 2022, Cancers CrossRef
21. Pathologic Versus Impending Fracture
    Maria Silvia Spinelli et al, 2019, Management of Bone Metastases CrossRef
22. Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
    Xupeng Chai et al, 2021, Frontiers in Oncology CrossRef
23. Tracking the Progression of Triple Negative Mammary Tumors over Time by Chemometric Analysis of Urinary Volatile Organic Compounds
    Mark Woollam et al, 2021, Cancers CrossRef
24. Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities
    Xin Li et al, 2018, Life Sciences CrossRef
25. Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
    Shinji Tsukamoto et al, 2023, Current Oncology CrossRef